Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vaughan

Showing results (71-80 of 486) with videos related to

Pageof 49
Sort By:
Geriatrics|May 1, 1983
Atypical presentations of malignant diseaseS A Grossman, W P Vaughan
Journal of Pharmaceutical Sciences|April 1, 1976
Simple transformation method for predicting plasma drug profiles from dissolution ratesD P Vaughan, R H Leach
Nature Communications|April 28, 2019
Water quality improvements offset the climatic debt for stream macroinvertebrates over twenty yearsIan P Vaughan, Nicholas J Gotelli
Bulletin of the World Health Organization|January 1, 1979
A comparison of cardiovascular measurements in the Gambia, Jamaica, and the United Republic of TanzaniaJ P Vaughan, W E Miall
European Journal of Clinical Pharmacology|January 1, 1976
General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapyD P Vaughan, G T Tucker
Cancer Research|May 1, 1983
Development of a cell kinetic approach to curative therapy of acute myelocytic leukemia in remission using the cell cycle-specific drug 1-beta-D-arabinofuranosylcytosine in a rat modelW P Vaughan, P J Burke
Behavioral and Neural Biology|October 1, 1981
Lithium chloride-produced prey aversion in the toad (Bufo americanus)P Mikulka, P Vaughan, J Hughes
The Journal of Pharmacy and Pharmacology|December 1, 1973
A note on the chemical change of pentazocine in aqueous acidic mediaD P Vaughan, A H Beckett
Geriatrics|January 1, 1983
Meeting the challenge of cancer control: a case in pointW P Vaughan, T P Waalkes
Mutation Research|March 1, 1993
Induction of the adaptive response of Escherichia coli to alkylation damage by the environmental mutagen, methyl chlorideP Vaughan, T Lindahl, B Sedgwick
Pageof 49

Showing results (71-80 of 486) with videos related to

Sort By:
Pageof 49
Geriatrics|May 1, 1983
Atypical presentations of malignant diseaseS A Grossman, W P Vaughan
Journal of Pharmaceutical Sciences|April 1, 1976
Simple transformation method for predicting plasma drug profiles from dissolution ratesD P Vaughan, R H Leach
Nature Communications|April 28, 2019
Water quality improvements offset the climatic debt for stream macroinvertebrates over twenty yearsIan P Vaughan, Nicholas J Gotelli
Bulletin of the World Health Organization|January 1, 1979
A comparison of cardiovascular measurements in the Gambia, Jamaica, and the United Republic of TanzaniaJ P Vaughan, W E Miall
European Journal of Clinical Pharmacology|January 1, 1976
General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapyD P Vaughan, G T Tucker
Cancer Research|May 1, 1983
Development of a cell kinetic approach to curative therapy of acute myelocytic leukemia in remission using the cell cycle-specific drug 1-beta-D-arabinofuranosylcytosine in a rat modelW P Vaughan, P J Burke
Behavioral and Neural Biology|October 1, 1981
Lithium chloride-produced prey aversion in the toad (Bufo americanus)P Mikulka, P Vaughan, J Hughes
The Journal of Pharmacy and Pharmacology|December 1, 1973
A note on the chemical change of pentazocine in aqueous acidic mediaD P Vaughan, A H Beckett
Geriatrics|January 1, 1983
Meeting the challenge of cancer control: a case in pointW P Vaughan, T P Waalkes
Mutation Research|March 1, 1993
Induction of the adaptive response of Escherichia coli to alkylation damage by the environmental mutagen, methyl chlorideP Vaughan, T Lindahl, B Sedgwick
Pageof 49